Bowen D - Search Results

1

Revised international prognostic scoring system for myelodysplastic syndromes.

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Greenberg PL, et al. Among authors: bowen d. Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27. Blood. 2012. PMID: 22740453 Free PMC article.

2

In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS).

Tauro S, Bowen DT. Tauro S, et al. Among authors: bowen dt. Leukemia. 1999 Mar;13(3):494-5. doi: 10.1038/sj.leu.2401337. Leukemia. 1999. PMID: 10086748 No abstract available.

3

Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure.

West RR, Stafford DA, White AD, Bowen DT, Padua RA. West RR, et al. Among authors: bowen dt. Blood. 2000 Mar 15;95(6):2093-7. Blood. 2000. PMID: 10706879 Free article.

4

Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.

Tauro S, Hepburn MD, Bowen DT, Pippard MJ. Tauro S, et al. Among authors: bowen dt. Haematologica. 2001 Oct;86(10):1038-45. Haematologica. 2001. PMID: 11602409

5

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.

Tauro S, Hepburn MD, Peddie CM, Bowen DT, Pippard MJ. Tauro S, et al. Among authors: bowen dt. Leukemia. 2002 May;16(5):785-90. doi: 10.1038/sj.leu.2402440. Leukemia. 2002. PMID: 11986938

6

No increase in age-specific incidence of myelodysplastic syndromes.

Germing U, Strupp C, Kündgen A, Bowen D, Aul C, Haas R, Gattermann N. Germing U, et al. Among authors: bowen d. Haematologica. 2004 Aug;89(8):905-10. Haematologica. 2004. PMID: 15339672

7

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, Soneji S, Leach J, Bowen D, Chapman C, Standen G, Massey E, Robinson L, Vadher B, Kaczmarski R, Janmohammed R, Clipsham K, Carr A, Vyas P. Sternberg A, et al. Among authors: bowen d. Blood. 2005 Nov 1;106(9):2982-91. doi: 10.1182/blood-2005-04-1543. Epub 2005 Aug 2. Blood. 2005. PMID: 16076868 Free article.

8

Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.

Vey N, Bosly A, Guerci A, Feremans W, Dombret H, Dreyfus F, Bowen D, Burnett A, Dennis M, Ribrag V, Casadevall N, Legros L, Fenaux P. Vey N, et al. Among authors: bowen d. J Clin Oncol. 2006 Jun 1;24(16):2465-71. doi: 10.1200/JCO.2005.03.9503. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651646 Clinical Trial.

9

Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application.

Bowen DT, Fenaux P, Hellstrom-Lindberg E, de Witte T. Bowen DT, et al. J Clin Oncol. 2008 Mar 1;26(7):1180; author reply 1181-2. doi: 10.1200/JCO.2007.15.2926. J Clin Oncol. 2008. PMID: 18309958 No abstract available.

10

Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.

Wulfert M, Küpper AC, Tapprich C, Bottomley SS, Bowen D, Germing U, Haas R, Gattermann N. Wulfert M, et al. Among authors: bowen d. Exp Hematol. 2008 May;36(5):577-86. doi: 10.1016/j.exphem.2008.01.004. Exp Hematol. 2008. PMID: 18439489 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,483 results

Search Page